News Classic

PPG Indus PPG is set to give its latest quarterly earnings report on Wednesday, 2024-10-16. Here’s what investors need to know before the announcement.

Analysts estimate that PPG Indus will report an earnings per share (EPS) of $2.15.

Anticipation surrounds PPG Indus’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Performance in Previous Earnings

During the last quarter, the company reported an EPS beat by $0.02, leading to a 2.79% drop in the share price on the subsequent day.

Here’s a look at PPG Indus’s past performance and the resulting price change:

Tracking PPG Indus’s Stock Performance

Shares of PPG Indus were trading at $128.5 as of October 14. Over the last 52-week period, shares are up 2.63%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analysts’ Take on PPG Indus

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on PPG Indus.

Analysts have given PPG Indus a total of 7 ratings, with the consensus rating being Neutral. The average one-year price target is $147.57, indicating a potential 14.84% upside.

Peer Ratings Comparison

In this comparison, we explore the analyst ratings and average 1-year price targets of Intl Flavors & Fragrances, DuPont de Nemours and RPM Intl, three prominent industry players, offering insights into their relative performance expectations and market positioning.

• The consensus among analysts is an Outperform trajectory for Intl Flavors & Fragrances, with an average 1-year price target of $109.78, indicating a potential 14.57% downside.
• For DuPont de Nemours, analysts project an Buy trajectory, with an average 1-year price target of $93.0, indicating a potential 27.63% downside.
• As per analysts’ assessments, RPM Intl is favoring an Neutral trajectory, with an average 1-year price target of $132.92, suggesting a potential 3.44% upside.

Peers Comparative Analysis Summary

The peer analysis summary provides a snapshot of key metrics for Intl Flavors & Fragrances, DuPont de Nemours and RPM Intl, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

Key Takeaway:

PPG Indus ranks in the middle for revenue growth among its peers. It ranks at the top for gross profit. It is at the bottom for return on equity.

Unveiling the Story Behind PPG Indus

PPG is a global producer of coatings. The company is the world’s largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG’s products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.

PPG Indus: Delving into Financials

Market Capitalization Highlights: Above the industry average, the company’s market capitalization signifies a significant scale, indicating strong confidence and market prominence.

Revenue Challenges: PPG Indus’s revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -1.6%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.

Net Margin: The company’s net margin is a standout performer, exceeding industry averages. With an impressive net margin of 11.01%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): The company’s ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.72%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): PPG Indus’s ROA excels beyond industry benchmarks, reaching 2.42%. This signifies efficient management of assets and strong financial health.

Debt Management: PPG Indus’s debt-to-equity ratio is below the industry average. With a ratio of 0.93, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

To track all earnings releases for PPG Indus visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 15, 2024 (GLOBE NEWSWIRE) — The global home sequential compression devices market (가정용 순차 압축 장치 시장) is estimated to flourish at a CAGR of 6.8% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for home sequential compression devices is estimated to reach US$ 1.9 billion by the end of 2031.

In the home sequential compression devices market, consumer education initiatives are emerging as significant drivers. As awareness grows about the benefits of compression therapy for various health conditions beyond the traditional scope, such as sports recovery and pregnancy-related swelling, demand for these devices is expanding.

Download Sample Copy of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85882

Manufacturers and healthcare providers are investing in educational campaigns to inform consumers about the therapeutic benefits and proper usage of sequential compression devices, thereby stimulating market growth.

Advancements in remote monitoring technology are shaping the market landscape. Integrated monitoring features in sequential compression devices allow healthcare providers to remotely track patient compliance and progress, optimizing treatment outcomes and reducing the need for in-person follow-ups. This trend aligns with the broader shift towards telehealth and remote patient monitoring, driving the adoption of home sequential compression devices as part of comprehensive remote care solutions.

Home Sequential Compression Devices Market: Competitive Landscape

The competitive landscape of the home sequential compression devices market is characterized by a mix of established players and emerging entrants.

Key companies like DJO Global, Inc., NormaTec, and BioCompression Systems, Inc. dominate with their extensive product portfolios and widespread distribution networks. Niche players focusing on specialized applications or innovative features are gaining traction.

The market is witnessing increased collaboration between manufacturers and healthcare providers to develop customized solutions and enhance patient outcomes.

As demand for home-based medical devices continues to rise, competition intensifies, prompting companies to innovate and differentiate to maintain their market positions. Some prominent players are as follows:

• Compression Solutions
• AIROS Medical Inc.
• Lympha Press USA
• Biocompression Systems
• Huntleigh Healthcare
• Globus Corporation
• Fisiopress
• Welbutech
• Devon Medical Products
• Tactile Medica

Product Portfolio

• Compression Solutions specializes in providing innovative compression therapy products for medical and wellness applications. With a commitment to quality and patient care, they offer a comprehensive range of garments and devices designed to improve circulation and manage lymphatic conditions effectively.
• AIROS Medical Inc. is a leading provider of pneumatic compression therapy systems for treating lymphedema and venous insufficiency. Their state-of-the-art devices offer customizable treatment options and advanced features to meet the diverse needs of patients and healthcare professionals.

Key Findings of the Market Report

• Intermittent pneumatic compression devices lead the home sequential compression devices market due to their versatility and effectiveness in managing vascular conditions.
• Venous thromboembolism is leading the home sequential compression devices market due to its high prevalence and need for long-term management.
• Online sales lead the home sequential compression devices market due to the convenience and accessibility of purchasing products directly from manufacturers or retailers.

To Get Sample PDF Brochure Here:

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85882

Home Sequential Compression Devices Market Growth Drivers & Trends

• Increasing incidence of conditions like lymphedema and venous insufficiency drives demand for home sequential compression devices for long-term management.
• Continuous innovation in device design and features enhances patient comfort, usability, and treatment efficacy, driving market growth.
• Growing elderly population worldwide fuels demand for home healthcare solutions, including sequential compression devices, to manage age-related vascular conditions.
• Preference for home-based treatment options over hospital stays accelerates the adoption of sequential compression devices for convenient and cost-effective management.
• Rising awareness of the importance of vascular health and preventive care prompts individuals to seek early intervention and adopt home-based treatment modalities. 

Global Home Sequential Compression Devices Market: Regional Profile

• North America leads with a mature market driven by a rising prevalence of chronic conditions like lymphedema and venous insufficiency. Key players like DJO Global, Inc. and BioCompression Systems, Inc. dominate, offering a wide range of devices tailored to patient needs and lifestyle preferences.
• In Europe, a strong emphasis on preventive healthcare and patient-centric treatment models shapes the market landscape. Companies like NormaTec and Game Ready lead innovation, offering advanced compression therapy systems that cater to diverse patient populations. The region’s aging population and increasing awareness of the benefits of home-based healthcare drive market growth.
• In the Asia Pacific region, rapid urbanization and healthcare infrastructure development fuel demand for home sequential compression devices. Leading players such as A&D Company, Limited and Daesung Maref Co., Ltd. cater to diverse patient needs, offering affordable and accessible solutions for managing vascular conditions.
• Increasing healthcare expenditure and government initiatives to promote home healthcare services drive market expansion, positioning the region as a key market for growth in the global home sequential compression devices market.

Home Sequential Compression Devices Market: Key Segments

By Device Type

• Intermittent Pneumatic Compression (IPC) Devices
• Lymphedema Pumps
• Foot and Calf Compression Devices
• Others

By Application

• Deep Vein Thrombosis (DVT)
• Venous Thromboembolism (VTE)
• Pulmonary Embolus (PE)
• Others

By Distribution Channel

• Retail Channels
• Online Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=85882&ltype=S

Explore More Trending Report by Transparency Market Research:

Active Pharmaceutical Ingredients (API) Market (医薬品原薬（API）市場) is projected to flourish at a CAGR of 6.4% from 2023 to 2031: TMR Report

CINV Existing and Pipeline Drugs Market (سوق أدوية CINV الحالية وخطوط الأنابيب) to reach US$ 3.2 billion in 2031, expanding at a CAGR of 5.8%: TMR Report

About Transparency Market Research 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

New York, United States, Oct. 15, 2024 (GLOBE NEWSWIRE) — The use of electric impulses to relax muscles, improve blood flow, repair tissues, and encourage bone formation is known as electrotherapy. Global demand for electrotherapy has increased as a result of the use of physiotherapy in the treatment of various ailments. Electrotherapy is the application of electrical impulses to relax muscles, enhance blood flow, heal tissues, and promote bone growth.

Market Dynamics

New Product Launches and Technological Advances Drive the Global Market

Technological advancements in interferential therapy, ultrasound therapy, and transcutaneous electrical nerve stimulation are anticipated to support market growth. Recent product innovations from manufacturers allow us to see how far technology has come. For instance, in February 2021, KT Tape LLC (US) unveiled the newest addition to its recovery product line, KT Recovery+ Wave. The KT Wave, the powerful electromagnetic technology previously only available at a doctor’s office, is transformed into a wearable, convenient solution by the FDA-approved wearable device KT Wave. It provides drug-free relief for sprains, arthritis, back pain, carpal tunnel syndrome, sports injuries, knee pain, and other symptoms. The increasing number of product launches and strategic moves made by manufacturers in the global electrotherapy market are expected to speed up market growth.

Download Free Sample Report PDF @ https://straitsresearch.com/report/electrotherapy-market/request-sample 

High Market Growth to Support the Launch of New Products Creates Tremendous Opportunities

New products that can help patients in various ways, including pain relief, have also been developed as electrotherapy technology advances. According to data from the US Bureau of Economic Analysis, domestic production of medical supplies and equipment is increasing in real output and value-added (BEA). The larger “Medical Equipment and Supplies Manufacturing” industry had USD 102 billion in gross output and USD 62 billion in value added in 2018. This includes the two most essential subcategories, “Surgical and Medical Instrument Manufacturing” (USD 45.9 billion) and “Surgical Appliance and Supplies Manufacturing” (USD 37.4 billion). The latter category, which includes ventilators, masks, and numerous other essential medical supplies, saw an increase in real output of nearly 90% during the period under consideration. Manufacturing of analytical laboratory instruments (121.8%), irradiation apparatus (468.0%), and electromedical and electrotherapeutic apparatus (418.1%) were among the sectors that experienced notable increases in real output.

Regional Analysis

Americas is the most significant shareholder in the global electrotherapy market and is expected to grow at a CAGR of 5.53% during the forecast period. The developed healthcare system, growing demand for electrotherapy, and the existence of significant regional players are all factors in the Americas’ 40.44% market share. Another aspect of the market’s growth in the region is the high rate of sports-related injuries. For instance, according to estimates from the Centers for Disease Control and Prevention (CDC), 273,272 children (age 17 or younger) were treated in emergency departments (EDs) in the US in 2016 for nonfatal traumatic brain injuries (TBIs) related to sports and recreation. It is estimated that 3.5 million children suffer injuries from sports-related incidents annually. Bicycling was the second riskiest sport, with about 417,000 injuries, while football and basketball were third and fourth, with 404,000 and 292,000 injuries, respectively. In addition, the increasing use of electrotherapy systems in treating sports injuries among professional athletes and sportsmen is thus another factor driving the market in North America.

Europe is expected to grow at a CAGR of 4.43% during the forecast period. The rise in diabetes prevalence and the resulting increase in diabetic nerve pain are blamed for the market expansion. According to the World Health Organization, there are about 60 million diabetics in Europe (WHO). Diabetes is increasing in prevalence among people of all ages in the European region, primarily due to increased overweight and obesity, a poor diet, and sedentary lifestyles. In addition, the region’s steadily rising cancer survivability rate and expanding geriatric population are also anticipated to contribute to the electrotherapy market’s expansion. High healthcare spending is also expected to fuel the market’s growth. According to a report released by the European Union, approximately 9.6% of the entire gross domestic product was spent on healthcare in European nations.

To Gather Additional Insights on the Regional Analysis of the Electrotherapy Market @ https://straitsresearch.com/report/electrotherapy-market/request-sample 

Key Highlights

• Based on the treatment type, the global electrotherapy market is bifurcated into extracorporeal shock wave therapy, interferential current therapy (IC), magnetic field therapy, ultrasound therapy, transcutaneous electrical nerve stimulation (TENS) therapy, micro-current therapy, transcutaneous spinal electro analgesia (TSE), pulsed short wave diathermy (PSWD), spinal cord stimulation (SCS), percutaneous electrical nerve stimulation (PENS). The transcutaneous electrical nerve stimulation (tens) therapy segment is the highest contributor to the market and is expected to grow at a CAGR of 6.13% during the forecast period.
• Based on the device type, the global electrotherapy market is bifurcated into transcutaneous electrical neural stimulator (TENS), electronic muscle stimulator (EMS), interferential stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS), microcurrent stimulator (MC) or microcurrent electrical neuromuscular stimulator (MENS). The transcutaneous electrical neural stimulator (TENS) segment owns the highest market share and is expected to grow at a CAGR of 5.91% during the forecast period.
• Based on the application, the global electrotherapy market is bifurcated into pain management, neuromuscular dysfunction, urine and fecal incontinence, acute and chronic edema, tissue repair, iontophoresis, orthopedics, and cardiology. The pain management segment is the highest contributor to the market and is expected to grow at a CAGR of 5.96% during the forecast period.
• Based on the end-user, the global electrotherapy market is bifurcated into hospitals and clinics, rehabilitation centers, and long-term care centers. The hospitals and clinics segment owns the highest market share and is expected to grow at a CAGR of 6.01% during the forecast period.
• Americas is the most significant shareholder in the global electrotherapy market and is expected to grow at a CAGR of 5.53% during the forecast period.

Competitive Players

1. AliMedInc
2. Cogentix Medical Inc
3. St. Jude Medical Inc
4. Zynex Medical
5. DJO Global Inc
6. Livanova Plc
7. Nevro Corp
8. Neurometrix Inc
9. Boston Scientific Corporation

Recent Developments

• October 2022-Electromedical Technologies, Inc., a pioneer in developing and producing bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, introduced its new next-generation flagship device, the WellnessPro Infinity™.

Segmentation

1. By Treatment Type
   1. Extracorporeal Shock Wave Therapy
   2. Interferential Current Therapy (IC)
   3. Magnetic Field Therapy
   4. Ultrasound Therapy
   5. Transcutaneous Electrical Nerve Stimulation (TENS) Therapy
   6. Micro-Current Therapy
   7. Transcutaneous Spinal Electro Analgesia (TSE)
   8. Pulsed Short WaveDiathermy (PSWD)
   9. Spinal Cord Stimulation (SCS)
   10. Percutaneous Electrical Nerve Stimulation (PENS)
2. By Device Type
   1. Transcutaneous Electrical Neural Stimulator (TENS)
   2. Electronic Muscle Stimulator (EMS)
   3. Interferential Stimulator (IF)
   4. High Voltage Pulsed Galvanic Stimulator (HVPGS)
   5. Microcurrent Stimulator (MC) Or Microcurrent Electrical Neuromuscular Stimulator (MENS)
3. By Applications
   1. Pain Management
   2. Neuromuscular Dysfunction
   3. Urine and Fecal Incontinence
   4. Acute and Chronic Edema
   5. Tissue Repair
   6. Iontophoresis
   7. Orthopedics
   8. Cardiology
4. By End-User
   1. Hospitals and Clinics
   2. Rehabilitation Centers
   3. Long-Term Care Centers
5. By Region
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East and Africa
   5. Latin America

Get Detailed Market Segmentation @ https://straitsresearch.com/report/electrotherapy-market/segmentation 

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (U.S.)

+91 8087085354 (India)

+44 203 695 0070 (U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.